Suptavumab: A Deep Dive into the REGN2222 Monoclonal Antibody REGN2222 is a monoclonal antibody designed to selectively inhibit IL18, a important mediator involved in severe respiratory distress syndrome https://haarisohwd279091.blog-gold.com/profile